ID
29853
Beschreibung
Study ID: 108414 Clinical Study ID: DBU108414 Study Title: TXA107979: A placebo-controlled, single blind, randomized two part study to investigate the tolerability, pharmacokinetics, and brainDopamine D3 receptor occupancy of increasing repeat doses ofGSK618334 for up to 21 days in healthy volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01036061 https://clinicaltrials.gov/ct2/show/NCT01036061 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: GSK618334 Study Indication: Substance Dependence Documentation part: Logs/Repeats - Adverse Event/Concomitant Medication/Repeat Assessment Check Questions
Link
https://clinicaltrials.gov/ct2/show/NCT01036061
Stichworte
Versionen (1)
- 24/04/18 24/04/18 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
24 aprile 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Tolerability, pharmacokinetics, and brain Dopamine D3 receptor occupancy of increasing repeat doses of GSK618334 in healthy adults NCT01036061
Logs/Repeats - Adverse Event/Concomitant Medication/Repeat Assessment Check Questions
Beschreibung
Logs/Repeats - Adverse Event/Concomitant Medication/Repeat Assessment Check Questions
Alias
- UMLS CUI-1
- C0220825
- UMLS CUI-2
- C1522634
- UMLS CUI-3
- C0877248
- UMLS CUI-4
- C2347852
Beschreibung
concomitant medications
Datentyp
boolean
Alias
- UMLS CUI [1]
- C2347852
Beschreibung
non-serious adverse events
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1518404
Beschreibung
serious adverse events
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1519255
Beschreibung
abnormal ECG measurements
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0522055
Beschreibung
Repeat haematology or clinical chemistry samples taken
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0008000
- UMLS CUI [1,2]
- C0018941
- UMLS CUI [1,3]
- C0200345
Beschreibung
urinalysis samples
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0042014
- UMLS CUI [1,2]
- C0200345
Beschreibung
ECG
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1623258
Beschreibung
vital signs
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0518766
Beschreibung
AIMS
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0450978
Beschreibung
BAS
Datentyp
boolean
Beschreibung
SAS
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0037315
Beschreibung
POMSB
Datentyp
boolean
Beschreibung
blood samples
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0005834
Beschreibung
Holter
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0013801
Beschreibung
Telemetry
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0039451
Beschreibung
Liver Event
Alias
- UMLS CUI-1
- C1556667
Beschreibung
If liver event occurred, stop investigational product, complete date stopped on Investigational Product form and contact GSK within 24 hours of occurrence of Liver event by phone or fax. NOTE: If the liver event meets the definition of an SAE, the SA!E form must be completed in Inform. lf lnFonn is unavailable, the SAE form should be faxed to GSK. * Obtain tests as per protocol * An unscheduled PK sample must be obtained within < insert time interval recommended by Clinical phannacokinetics representative> of last dose * Complete Liver Event Forms (completed Liver Event Forms do not need to be supplied to CSK within 24 hours)
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0232741
- UMLS CUI [1,2]
- C0008000
- UMLS CUI [1,3]
- C0587081
Ähnliche Modelle
Logs/Repeats - Adverse Event/Concomitant Medication/Repeat Assessment Check Questions
C1522634 (UMLS CUI-2)
C0877248 (UMLS CUI-3)
C2347852 (UMLS CUI-4)
C0018941 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,3])
C0200345 (UMLS CUI [1,2])
C0008000 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])